Crossix Solutions to Share Data-Driven Patient Journey Insights at the Advertising Research Foundation’s Health & Wellness Event
Ira Haimowitz will discuss how clinical data is being used in innovative ways to better understand the impact of DTC advertising on patient outcomes
NEW YORK, NY – July 7, 2017 – Ira Haimowitz, Ph.D., VP, Product Strategy at Crossix, will lead a speaking session at the Advertising Research Foundation (ARF)’s Health & Wellness Event, “The Patient Journey – The Maze of Nowadays,” on Tuesday, August 8, 2017. The event is being held at WebMD’s offices in New York City. Based on a meta-analysis of multiple diabetes media campaigns, Dr. Haimowitz’s presentation, “The Impact of DTC Advertising on the Patient Journey,” will discuss:
- How clinical data combined with other health and non-health data enables a deeper understanding of patient behaviors by connecting media and marketing efforts to key moments in a patient’s journey
- Where and when to intercept the patient journey with DTC advertising for best results
- How to use data to understand and optimize marketing implementation
The event will begin promptly at 1:30 p.m. ET. For more information about The ARF’s Health & Wellness Event, click here. For those unable to attend in person, a PDF version of the presentation can be shared following the event. Please contact us here or via firstname.lastname@example.org to request a copy.
About Ira Haimowitz
In his role as Vice President, Product Strategy at Crossix, Ira Haimowitz is dedicated to managing key client relationships and accelerating new product innovation, with a specific focus on the company’s rapidly growing digital, TV, and healthcare professional (HCP) analytics offerings.
Ira brings more than 20 years of pharmaceutical, consumer packaged goods (CPG), agency, and consulting expertise to Crossix. He has been recognized for developing many transformative analytics solutions, including media planning and optimization strategies, cross-channel campaign measurement, segmentation, targeting, and business intelligence dashboards. Prior to joining Crossix, Ira led new product development for Information Resources (IRI), nurturing client relationships in the CPG and over-the-counter (OTC) healthcare verticals. Before IRI, he led agency analytics groups at Wunderman and CementBloc, and worked client-side at General Electric, Pfizer, and Organon.
He also previously led the Pharmaceutical Management Science Association (PMSA) as President, and served on their Board of Directors for seven years. A seasoned writer, Ira has shared his thought leadership expertise through extensive publishing and speaking experience, including authoring the book Healthcare Relationship Marketing, a practical overview and resource guide for the design and measurement of pharmaceutical relationship marketing (RM) programs. Ira received his Ph.D. in Computer Science, as well as a Bachelor of Science degree in Mathematics, from the Massachusetts Institute of Technology.
About Crossix Solutions
Crossix empowers healthcare companies and companies that care about health to plan, measure and optimize their marketing and communication initiatives. Fueled by its Distributed Data Network (DDN) technology and the industry’s most comprehensive set of health and non-health data, which encompasses more than 250 million U.S. consumers, Crossix analytics inform strategic decisions, maximize business results, and drive improved patient outcomes. Crossix connects Rx, OTC, CPG, clinical, medical claims, hospital, consumer and media data with best-in-class privacy safeguards far exceeding HIPAA requirements. Through an unrivaled commitment to innovation and its first-of-their-kind partnerships, Crossix offers an expansive suite of audience and media optimization solutions across programmatic advertising, addressable TV, mobile marketing, search, Point of Care, and beyond. Founded in 2004, Crossix is headquartered in New York City. For more information, visit www.crossix.com.